RBC Capital Reiterates Outperform on Nevro, Maintains $33 Price Target
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Shagun Singh has reiterated an 'Outperform' rating on Nevro (NYSE:NVRO) and maintained a price target of $33.
August 17, 2023 | 2:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated an 'Outperform' rating on Nevro and maintained a price target of $33.
The reiteration of an 'Outperform' rating by RBC Capital indicates a positive outlook for Nevro. The maintained price target of $33 suggests that the analyst believes the stock is still undervalued. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100